The Journal of Thoracic and Cardiovascular Surgery
Volume 117, Issue 4 , Pages 751-758 , April 1999

Experimental and clinical evaluation of a new synthetic, absorbable sealant to reduce air leaks in thoracic operations

  • Paolo Macchiarini, MD, PhD

      Affiliations

    • Departments of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie-Lannelongue Hôpital, Paris-Sud University, Le Plessis Robinson, France
  • ,
  • John Wain, MD

      Affiliations

    • Thoracic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Mass
  • ,
  • Susan Almy, MS

      Affiliations

    • Statistics Unlimited, Inc, Westford, Mass.
  • ,
  • Philippe Dartevelle, MD

      Affiliations

    • Departments of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie-Lannelongue Hôpital, Paris-Sud University, Le Plessis Robinson, France

Received 24 July 1998 ,Revised 23 November 1998 ,Accepted 23 November 1998.

  • Image Result

    The surgical sealant components (A) and life cycle (B).

    The surgical sealant components (A) and life cycle (B).

  • Image Result

    The section taken just proximal to the sealant plug (arrow) shows an organized fibrovascular scar that is bridging across and filling the entire bronchial lumen (note hyaline cartilage lower right and

    The section taken just proximal to the sealant plug (arrow) shows an organized fibrovascular scar that is bridging across and filling the entire bronchial lumen (note hyaline cartilage lower right and left side of frame). The sealants present right center frame surrounded by a cuff of macrophages; note the lack of foreign body giant cell formation and viable cells in contact with it. (Hematoxylin and eosin stain; original magnification, ×25.)

  • Image Result
    High-power field of the inflammatory reaction against the sealant 19 days after the operation. As in our preclinical experience, the sealant (*) was surrounded by a cuff of large macrophages, fibrobla

    High-power field of the inflammatory reaction against the sealant 19 days after the operation. As in our preclinical experience, the sealant (*) was surrounded by a cuff of large macrophages, fibroblasts, and lymphocytes. (Hematoxylin and eosin stain; original magnification, ×40.)

 Address for reprints: Paolo Macchiarini, MD, PhD, Department of Thoracic and Vascular Surgery, Heidehaus Hospital (Hannover Medical School), 70, Leineufer, D-30419, Hannover, Germany.

☆☆ 12/1/96206

PII: S0022-5223(99)70296-5

The Journal of Thoracic and Cardiovascular Surgery
Volume 117, Issue 4 , Pages 751-758 , April 1999